Call for Abstract
Scientific Program
4th International Conference on Biomarkers & Clinical Research, will be organized around the theme “Impact of Biomarker Developments in Health Diagnostics and Clinical Research”
Biomarkers-2013 is comprised of 13 tracks and 60 sessions designed to offer comprehensive sessions that address current issues in Biomarkers-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Protein biomarkers
- Track 1-2Fluorescent biomarkers
- Track 1-3Blood biomarkers: Serum and blood cells
- Track 1-4Cancer biomarkers
- Track 2-1Next gen sequencing
- Track 2-2Personalized genome sequencing
- Track 2-3Micro RNA sequencing
- Track 2-4SNP biomarkers
- Track 2-5Biomarkers for karotyping
- Track 2-6Immuno flouscent biomarkers
- Track 2-7Molecular imaging biomarkers
- Track 3-1Transcription analysis and profiling
- Track 3-2Microarray data analysis
- Track 3-3Molecular biomarkers
- Track 3-4si-RNA and mi-RNA
- Track 4-1Data mining methods
- Track 4-2Genomic and proteomic approaches
- Track 5-1Patient segmentation and stratification: Successful integration of diagnostic tools
- Track 5-2Clinical data annotation: Classification distribution metrics, pattern recognition
- Track 5-3Perspectives on integrated approach to biomarkers
- Track 5-4Statistics in clinical studies
- Track 6-1Case study and data management
- Track 6-2Clinical and non clinical biomarkers
- Track 6-3Medical devices
- Track 6-4Pharmacovigilance
- Track 6-5Reproductive technologies
- Track 6-6Bioethics and intellectual property rights
- Track 7-1Data mining methods
- Track 7-2Genomic and proteomic approaches
- Track 7-3Metabolomics and metabonomics
- Track 7-4Computational biology in biomarker discovery
- Track 7-5Biomarkers and system biology
- Track 8-1Viral infections
- Track 8-2Pathogenic infections
- Track 8-3Bacterial infections
- Track 8-4Biomarkers vaccines
- Track 9-1Epigenetic biomarkers
- Track 9-2Detection and measurement of endogenous substances
- Track 9-3Internal exposure and genetic susceptibility to drugs and chemicals
- Track 9-4Toxicodynamic parameters in pathological and biochemical changes
- Track 9-5Pharmacodynamic parameters in pathological and biochemical changes
- Track 10-1Metabolic disorders
- Track 10-2Genetic disorders
- Track 10-3Cardiac disorders
- Track 10-4Inborn errors
- Track 10-5Neurological disorders
- Track 10-6Auto-immune disorders
- Track 11-1RT-PCR
- Track 11-2Molecular imaging and dynamics
- Track 11-3Immunological techniques
- Track 11-4Biochemical assays and profiling
- Track 11-5Chromatographic techniques
- Track 11-6Spectroscopic techniques
- Track 12-1Interactions of biomarkers with nanoparticles
- Track 12-2Biological and biomedical applications
- Track 12-3Optical properties
- Track 12-4Nanodevices
- Track 13-1Reproductive and developmental toxicity
- Track 13-2Pulmonary toxicity, hepatotoxicity and nephrotoxicity
- Track 13-3Immunotoxicity and autoimmune diseases